{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:44:14Z","timestamp":1755801854284,"version":"3.44.0"},"reference-count":0,"publisher":"MJH Life Sciences","issue":"3907","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,6]]},"abstract":"<jats:p>Zenocutuzumab-zbco, a novel bispecific antibody targeting HER2 and HER3, has demonstrated promising efficacy in non\u2013small cell lung cancer (NSCLC) and pancreatic adenocarcinoma. In early-phase clinical trials, it has shown an objective response rate of approximately 34% in HER2-amplified NSCLC and a disease control rate exceeding 70% in pancreatic adenocarcinoma with  NRG1  fusions. By disrupting HER3-driven oncogenic signaling, zenocutuzumab effectively inhibits tumor proliferation and enhances therapeutic outcomes. Its safety profile remains favorable, with most adverse effects being mild to moderate. This editorial explores the clinical potential of zenocutuzumab in reshaping treatment strategies for NSCLC and pancreatic adenocarcinoma.<\/jats:p>","DOI":"10.46883\/2025.25921048","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T19:38:14Z","timestamp":1755718694000},"page":"298-300","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling the Potential of Zenocutuzumab: A Breakthrough in NSCLC and Pancreatic Adenocarcinoma Treatment"],"prefix":"10.46883","member":"25947","published-online":{"date-parts":[[2025,8,14]]},"container-title":["ONCOLOGY"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T19:38:15Z","timestamp":1755718695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cancernetwork.com\/view\/unveiling-the-potential-of-zenocutuzumab-a-breakthrough-in-nsclc-and-pancreatic-adenocarcinoma-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":0,"issue-title":["August 2025"],"journal-issue":{"issue":"3907","published-online":{"date-parts":[[2025,8,11]]},"published-print":{"date-parts":[[2025,8,6]]}},"URL":"https:\/\/doi.org\/10.46883\/2025.25921048","relation":{},"ISSN":["0890-9091"],"issn-type":[{"type":"print","value":"0890-9091"}],"subject":[],"published":{"date-parts":[[2025,8,6]]}}}